Congress Materials – American Academy of Neurology (AAN 2025)
2025 American Academy of Neurology | Apr 5-9 | San Diego, CA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Complications in patients with myasthenia gravis treated with oral corticosteroids
Zhiwen Liu, Louis Jackson, Jacqueline Pesa, Alicia K Campbell, Zia Choudhry, Nizar Souayah
Design of a digital solution to improve myasthenia gravis patient symptom tracking in routine clinical care
Srikanth Muppidi, Joshua Alpers, Ashley EL Anderson, Nicholas Silvestri, Nicholas Streiche, Ananda Vishnu Pandurangadu, Hari Jayaraman, Archit Gupta, Nolan Campbell, Zia Choudhry
Economic burden of Myasthenia Gravis Exacerbation and Crisis from US Payer Perspective
Daniel Labson, Qian Cai, Kavita Gandhi, Maria Ait-Tihyaty, Andreas Nikolaou, Winghan Jacqueline Kwong
Efficacy of Nipocalimab, a Novel Neonatal Fragment Crystallizable Receptor Blocker, as Measured using Quantitative Myasthenia Gravis Assessment: Findings from the Phase 3 Placebo-Controlled Vivacity-MG3 Study
Sindhu Ramchandren, Maria Ait-Tihyaty, Ibrahim Turkoz, Kavita Gandhi, Richard J. Nowak
Healthcare costs in a commercially insured population of patients with generalized myasthenia gravis and related clinical events
Louis Jackson, Jacqueline Pesa, Alicia K Campbell, Nizar Souayah, Zhiwen Liu
Identifying risk factors for predicting exacerbation and symptom worsening—a retrospective cohort study of patients with Myasthenia Gravis in the United States
Zia Choudhry, Minjee Park, Pushpa Narayanaswami, Nizar Souayah, Raghav Govindarajan, Michael Kutch, Amaia Zurinaga Gutierrez, Aurélie Chekroun Martinot, Nolan Campbell, Richard J Nowak
Long-Term Safety and Efficacy of Nipocalimab in Generalized Myasthenia Gravis: Vivacity-MG3 Open-Label Extension Phase Results
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard J. Nowak, Constantine Farmakidis, Vera Bril, Jan De Bleecker, Huan Yang, Eduard Minks, Jin-Sung Park, Mariusz Grudniak, Marek Smilowski, Teresa Sevilla, Sarah Hoffmann, Kumaraswamy Sivakumar, Eriene Youssef, Panna Sanga, Keith Karcher, Yaowei Zhu, John Sheehan, Hong Sun
Long-term Use of Oral Corticosteroids and Overall Survival Among Patients with Myasthenia Gravis: A Nationwide Population-based Study
Qian Cai, Kavita Gandhi, Nurgul Batyrbekova, Gabriel Isheden, Maria Ait-Tihyaty, Winghan Jacqueline Kwong
Real-world Interaction between Pregnancy and Generalized Myasthenia Gravis
Louis Jackson, Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Melanie Jacobson, Béatrice Libchaber, Francesca Lee, Dominic Pilon, Zia Choudhry, Neelam Goyal
Real-world Treatment Patterns Among Patients with Generalized Myasthenia Gravis
Kavita Grover, Kavita Gandhi, Martin Cloutier, Geoffroy Coteur, Maryia Zhdanava, Antoine C El Khoury, Porpong Boonmak, Qian Cai, Anabelle Tardif-Samson, Maria Ait-Thiyaty, Yuxi Wang, Zia Choudhry, Nicholas J. Silvestri
Serological Testing Patterns Among Individuals with Myasthenia Gravis: Implications for Patient Care
Joshua N. Liberman, Jacqueline A. Pesa, Jonathan D. Darer, Xiaoyun Yang, Louis A.Jackson, Artem Sergeyenko, Nolan Campbell, Richard J. Nowak
Treatment-Related Characteristics Among Younger Women with Generalized Myasthenia Gravis
Jacqueline Pesa, Louis Jackson, Alex Keenan, Nolan Campbell, Gregor Gibson, Joe Conyers, Neelam Goyal
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.